SRTS insider trading
NasdaqCM HealthcareSensus Healthcare, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.
Company website: sensushealthcare.com
SRTS insider activity at a glance
FilingIQ has scored 239 insider transactions for SRTS since Jun 3, 2016. The most recent filing in our index is dated May 12, 2026.
Across the full history, 28 open-market purchases
and 161 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SRTS insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SRTS?
- FilingIQ tracks 239 Form 4 insider transactions for SRTS (Sensus Healthcare, Inc.), covering filings from Jun 3, 2016 onwards. 2 of those were filed in the last 90 days.
- Are SRTS insiders net buyers or net sellers?
- Across the full Form 4 history for SRTS, 28 transactions (12%) were open-market purchases and 161 (67%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SRTS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SRTS in?
- Sensus Healthcare, Inc. (SRTS) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $63.72M.
Methodology & sources
Every SRTS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.